More from Gemini:
As of today, October 26, 2023, there is no Roche blood test specifically marketed for breast cancer detection available in Australia. However, Roche Diagnostics does offer several blood tests used in the context of breast cancer, but they serve different purposes:
1. CA 15-3: This test measures the level of a protein called CA 15-3 in the blood. Elevated levels can be a sign of breast cancer, but it can also be caused by other conditions. This test is usually used to monitor patients who have already been diagnosed with breast cancer, rather than for initial diagnosis.
2. CEA: This test measures the level of a protein called carcinoembryonic antigen (CEA) in the blood. Like CA 15-3, elevated levels can be a sign of breast cancer, but it can also be caused by other conditions. This test is also not typically used for initial diagnosis, but rather for monitoring or diagnosis of recurrence in some cases.
3. HER2 test: This test can be done on blood or tissue samples and looks for the presence of the HER2 gene. The HER2 gene can cause breast cancer cells to grow and divide more quickly. Knowing if a patient has the HER2 gene can help doctors determine the best course of treatment. This test is used for both diagnosis and treatment planning in some cases.It's important to remember that no single blood test can definitively diagnose breast cancer. Doctors typically use a combination of tests and imaging scans to make a diagnosis.
Additional Points:Roche is currently developing new blood tests for cancer detection, including some for breast cancer. However, these are still in the research and development phase and not yet available for clinical use.You can find more information about Roche Diagnostics and their products on their Australian website: [invalid URL removed]For information about breast cancer diagnosis and screening in Australia, you can visit the website of the Cancer Council Australia: https://www.cancer.org.au/It's crucial to consult with your doctor if you have any questions or concerns about breast cancer screening or specific tests. They can provide accurate and personalized information based on your individual situation and risk factors.
- Forums
- ASX - By Stock
- IIQ
- Ann: INOVIQ detects 19% more breast cancers than leading test
Ann: INOVIQ detects 19% more breast cancers than leading test, page-34
-
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
43.0¢ |
Change
-0.005(1.15%) |
Mkt cap ! $47.95M |
Open | High | Low | Value | Volume |
43.5¢ | 43.5¢ | 43.0¢ | $4.59K | 10.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12325 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12325 | 0.430 |
5 | 44773 | 0.425 |
1 | 12500 | 0.420 |
1 | 10000 | 0.410 |
3 | 17283 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 10000 | 1 |
0.445 | 8500 | 1 |
0.450 | 24522 | 1 |
0.460 | 6850 | 1 |
0.465 | 1195 | 1 |
Last trade - 13.30pm 15/11/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online